Nuclear Energy Stocks March: Two Buys for March Investing
As the energy transition gains pace, nuclear power moves back into the spotlight. This article breaks down two stock ...
What Customers Say About No Annual Fee Travel Credit Cards
Learn what customers are saying about no annual fee travel credit cards. Gain insights to help you choose the right card for your travels.
22,814 articles
Exclusive: Yuliya Barabash Says Regulated Winners Rise
Regulatory tightening is reshaping crypto’s path. Barabash argues the most regulated platforms may become the biggest...
Back From Dead: The Trade Desk Surges on AI Ad Hopes
The Trade Desk jumps about 26% as OpenAI reportedly weighs a partnership to monetize ads through its platform, aided ...
SEC Proposes Guidelines Securities Laws for Crypto Regulation
The SEC submitted interpretive guidance to OIRA to clarify how federal securities laws could apply to crypto assets. ...
Greg Abel Running Berkshire: Early Moves Define Era
Greg Abel is redefining Berkshire Hathaway’s course with three bold moves: pruning a laggard investment, expanding ho...
Cathie Wood Goes Bargain: 3 Stocks She Just Bought
Cathie Wood Goes Bargain highlights how Ark Invest’s founder targets beaten-down growth bets for long-term gains. Her...
Wall Street Quietly Pricing in $100 Oil, Energy Winners Emerge
ExxonMobil and Chevron are rallying as investors price in a richer oil regime, with big-cap budgets and buyback plans...
Oil Price Craters on Reports That G7 Could Release 400M
Oil prices plummet after a Reuters-style rumor that the G7 may tap 400 million barrels from strategic reserves. Crypt...
Bitcoin Price Analysis: What’s the Short-Term Path for BTC?
Bitcoin steadies above $60k as traders weigh a delicate recovery against stubborn resistance. The coming days will cl...
Capitulation Deepens; 140,000 Exit Short-Term Holders
Bitcoin is under renewed pressure as on-chain signals show a large drawdown from the short-term holder cohort. About ...
Ethereum Price Defends $2,000 as RSI Near Oversold Levels
Ethereum holds the $2,000 line as RSI dips toward oversold. Traders await a decisive move as volumes ease and liquidi...
Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status